AbstractTumor nectosis factor (TNF) receptors are key players in inflammation and immune regulation. A new member of this family, termed death receptor-6 (DR6), has been identified. Like other death receptors, DR6 is a type I transmembrane receptor, possesses four extracellular cysteine-rich motifs and a cytoplasmic death domain. DR6 is expressed in most human tissues and abundant transcript was detected in heart, brain, placenta, pancreas, thymus, lymph node and several non-lymphoid cancer cell lines. DR6 interacts with TRADD, which has previously been shown to associate with TNFR1. Furthermore, ectopic expression of DR6 in mammalian cells induces apoptosis and activation of both NF-κB and JNK
Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase, is a signa...
Signaling by receptors in the TNF receptor (TNFR) superfamily mediate biological outcomes ranging fr...
AbstractBackground Two receptors that contain the so-called ‘death domain’ have been described to da...
AbstractTumor nectosis factor (TNF) receptors are key players in inflammation and immune regulation....
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/116991/1/feb2s0014579398007911.pd
Death receptor-6 (DR6/TNFRsf21/CD358) is a receptor from the TNFR superfamily that likely participat...
AbstractDeath receptor 6 (DR6) is a member of the death domain-containing receptors that belong to t...
AbstractDeath receptor 6 (DR6/TNFRSF21) is a death domain-containing receptor of the TNFR superfamil...
AbstractDeath receptor 4 (DR4) is a recently described receptor for the cytotoxic ligand TRAIL that ...
Programmed cell death or apoptosis is a genetically based mechanism that has evolved to eliminate su...
Death receptors and their ligands exert important regulatory functions in the maintenance of tissue ...
Death receptor 6 (DR6) is an orphan member of the TNF receptor superfamily and controls cell death a...
ARA267-alpha is a newly identified androgen receptor coactivator. In order to further elucidate its ...
ARA267-alpha is a newly identified androgen receptor coactivator. In order to further elucidate its ...
doi:10.1242/jcs.01610 Apoptosis or programmed cell death is a common property of multicellular organ...
Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase, is a signa...
Signaling by receptors in the TNF receptor (TNFR) superfamily mediate biological outcomes ranging fr...
AbstractBackground Two receptors that contain the so-called ‘death domain’ have been described to da...
AbstractTumor nectosis factor (TNF) receptors are key players in inflammation and immune regulation....
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/116991/1/feb2s0014579398007911.pd
Death receptor-6 (DR6/TNFRsf21/CD358) is a receptor from the TNFR superfamily that likely participat...
AbstractDeath receptor 6 (DR6) is a member of the death domain-containing receptors that belong to t...
AbstractDeath receptor 6 (DR6/TNFRSF21) is a death domain-containing receptor of the TNFR superfamil...
AbstractDeath receptor 4 (DR4) is a recently described receptor for the cytotoxic ligand TRAIL that ...
Programmed cell death or apoptosis is a genetically based mechanism that has evolved to eliminate su...
Death receptors and their ligands exert important regulatory functions in the maintenance of tissue ...
Death receptor 6 (DR6) is an orphan member of the TNF receptor superfamily and controls cell death a...
ARA267-alpha is a newly identified androgen receptor coactivator. In order to further elucidate its ...
ARA267-alpha is a newly identified androgen receptor coactivator. In order to further elucidate its ...
doi:10.1242/jcs.01610 Apoptosis or programmed cell death is a common property of multicellular organ...
Tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase, is a signa...
Signaling by receptors in the TNF receptor (TNFR) superfamily mediate biological outcomes ranging fr...
AbstractBackground Two receptors that contain the so-called ‘death domain’ have been described to da...